News
News Center
2020-07-07
Jiuzhitang Maker has signed an agreement with TianTan Hospital—China's first clinical trial for an imported stem-cell new drug is set to begin soon!
+
2020-06-04
Jiuzhitang Maker hosts the "Beautiful Moments, Captured by Technology" photography contest
To advance the company’s corporate culture and enrich employees' leisure activities, Jiuzhitang Maker hosted a photography competition on May 20, 2020, themed "Beautiful Moments Captured by Technology."
+
2020-05-15
On May 14, Wu Zuzhe, an academician of the Chinese Academy of Sciences and researcher at the Academy of Military Medical Sciences, along with a delegation of nine members, visited and inspected Jiuzhitang Maker's Daxing production base.
+
2020-04-13
As a pioneer and leader in domestic stem-cell pharmaceuticals, Jiuzhitang Maker feels duty-bound to contribute to the fight against the pandemic. Actively responding to the government’s call, the company has mobilized its research teams to submit the project proposal titled "Mesenchymal Stem Cell Therapy from Bone Marrow for Treating Lung Damage Caused by Novel Coronavirus Pneumonia," which has now been successfully approved for funding.
+
2020-04-09
Recently, Jiuzhitang Maker received financial support from Daxing District to boost the development of the pharmaceutical and healthcare industry. The project was selected following a review process conducted by the Daxing District Biomedical Industry Development Leading Group and the Daxing District Industrial Development Promotion Leading Group, in accordance with the "Provisional Measures for Promoting the Development of the Pharmaceutical and Healthcare Industry in Daxing District."
+
2020-03-16
China's Practices in Developing Stem Cell Drugs in Compliance with FDA Regulatory Requirements
You may have heard of the FDA in the news, or perhaps seen the words "FDA-approved" in other advertisements—so what exactly makes the FDA so remarkable? And why is "FDA certification" widely regarded as the highest honor and guarantee of product quality?
+
2020-03-16
Make quality your belief—Meiko’s “Quality Month” Training
Quality is the lifeblood of a company—and its very reputation. By fostering a scientific understanding of quality management and enhancing employees' awareness of quality, we can strengthen the company’s quality management system, ultimately ensuring reliable quality for our products.
+
2020-02-20
Jiuzhitang Maker's stem-cell-based new drug receives approval for clinical trials
Great news! Jiuzhitang Maker's stem-cell-based new drug has received approval for clinical trials! This marks the first time the Center for Drug Evaluation (CDE) under China’s National Medical Products Administration has approved a clinical trial using imported stem cells, as well as the first trial employing bone-marrow-derived mesenchymal stem cells. It’s also the first-ever clinical study to explore stem cells as a treatment for major neurological conditions.
+
2020-02-03
New trends, new opportunities — Join us and let your dreams take flight together!
Jiuzhitang Maker is now recruiting distributors nationwide—join us today!
+
Here is the title—h1 placeholder text
Copyright © Jiuzhitang Maker (Beijing) Cell Technology Co., Ltd.
Powered by: 300.cn SEO | Privacy Policy